InsiderTrades.com logo
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
From Priority Gold   |   Ad
Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.
Click here for your free guide
Hongming Chen net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Hongming Chen Biography and Net Worth

Insider of KALA BIO
Dr. Chen has served as our Chief Scientific Officer since October 2014. Prior to that, Dr. Chen served as our Executive Vice President of Research from October 2013 to October 2014 and our Vice President of Research from January 2010 to October 2013. Prior to joining us, Dr. Chen served as Director of Formulation Development at TransForm Pharmaceuticals Inc., or TransForm, from 2000 to January 2010. Before joining TransForm, Dr. Chen conducted vaccine delivery research and development at AstraZeneca plc from 1997 to 2000, and at Merck & Co., Inc. from 1996 to 1997. Dr. Chen is a member of the National Academy of Engineering, the College of Fellows of the American Institute for Medical and Biological Engineering and the College of Fellows of the Controlled Release Society. Dr. Chen received a B.S. in Chemical Engineering from The University of Texas at Austin in 1992 and both an M.S. and a ScD. in Chemical Engineering from the Massachusetts Institute of Technology.

How do I contact Hongming Chen?

The corporate mailing address for Dr. Chen and other KALA BIO executives is 490 ARSENAL WAY SUITE 120, WATERTOWN MA, 02472. KALA BIO can also be reached via phone at (781) 996-5252 and via email at [email protected]. Learn More on Hongming Chen's contact information.

Has Hongming Chen been buying or selling shares of KALA BIO?

Hongming Chen has not been actively trading shares of KALA BIO during the last ninety days. Most recently, Hongming Chen sold 9,449 shares of the business's stock in a transaction on Tuesday, October 26th. The shares were sold at an average price of $1.80, for a transaction totalling $17,008.20. Learn More on Hongming Chen's trading history.

Who are KALA BIO's active insiders?

KALA BIO's insider roster includes Todd Bazemore (COO), Romulus Brazzell (Insider), Hongming Chen (Insider), Mark Iwicki (CEO), and Mary Reumuth (CFO). Learn More on KALA BIO's active insiders.

Are insiders buying or selling shares of KALA BIO?

In the last twelve months, insiders at the sold shares 2 times. They sold a total of 5,766 shares worth more than $38,817.45. The most recent insider tranaction occured on January, 4th when insider Eric Trachtenberg sold 1,227 shares worth more than $8,269.98. Insiders at KALA BIO own 13.4% of the company. Learn More about insider trades at KALA BIO.

Information on this page was last updated on 1/4/2024.

Hongming Chen Insider Trading History at KALA BIO

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/26/2021Sell9,449$1.80$17,008.20View SEC Filing Icon  
6/28/2021Sell2,452$5.77$14,148.04View SEC Filing Icon  
See Full Table

Hongming Chen Buying and Selling Activity at KALA BIO

This chart shows Hongming Chen's buying and selling at KALA BIO by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

KALA BIO Company Overview

KALA BIO logo
KALA BIO, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for the treatment of eye diseases. The company's product candidates include KPI-012, which is in Phase 2b clinical trial for the treatment of persistent corneal epithelial defects; EYSUVIS for the short-term treatment of the signs and symptoms of dry eye disease; and INVELTYS, a topical twice-a-day ocular steroid for the treatment of post-operative inflammation and pain following ocular surgery. Its preclinical development product, including KPI-014 for the treatment of rare inherited retinal diseases. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts.
Read More

Today's Range

Now: $6.35
Low: $6.32
High: $6.35

50 Day Range

MA: $7.40
Low: $6.33
High: $7.99

2 Week Range

Now: $6.35
Low: $5.10
High: $19.35

Volume

1,185 shs

Average Volume

25,195 shs

Market Capitalization

$17.91 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
From Priority Gold   |   Ad
Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.
Click here for your free guide